150 related articles for article (PubMed ID: 36427171)
21. Female fertility preservation: Impact of cancer on ovarian function and oocyte quality.
Fabiani C; Ferrante MG; Meneghini C; Licata E; Paciotti G; Gallo M; Schiavi M; Spina V; Guarino A; Caserta D; Rago R
Int J Gynaecol Obstet; 2022 Jan; 156(1):166-171. PubMed ID: 33837528
[TBL] [Abstract][Full Text] [Related]
22. Is ovarian recovery after chemotherapy in young patients with early breast cancer influenced by controlled ovarian hyperstimulation for fertility preservation or tumor characteristics? Results of a prospective study in 126 patients.
Mailliez A; Pigny P; Bogart E; Keller L; D'Orazio E; Vanseymortier M; Le Deley MC; Decanter C
Int J Cancer; 2022 Jun; 150(11):1850-1860. PubMed ID: 35038360
[TBL] [Abstract][Full Text] [Related]
23. Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis.
Friedler S; Koc O; Gidoni Y; Raziel A; Ron-El R
Fertil Steril; 2012 Jan; 97(1):125-33. PubMed ID: 22078784
[TBL] [Abstract][Full Text] [Related]
24. Ovarian stimulation for fertility preservation in an oncology patient with etonogestrel implant in place.
Rushing JS; Appiah L; Polotsky AJ; Murray S; Foust E; Hassell K; Roeca C
J Assist Reprod Genet; 2021 Feb; 38(2):513-516. PubMed ID: 33409752
[TBL] [Abstract][Full Text] [Related]
25. Severe ovarian hyperstimulation syndrome associated with long-acting GnRH agonist in oncofertility patients.
Christ J; Herndon CN; Yu B
J Assist Reprod Genet; 2021 Mar; 38(3):751-756. PubMed ID: 33471229
[TBL] [Abstract][Full Text] [Related]
26. Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation.
Almog B; Azem F; Gordon D; Pauzner D; Amit A; Barkan G; Levin I
Fertil Steril; 2012 Oct; 98(4):957-60. PubMed ID: 22763097
[TBL] [Abstract][Full Text] [Related]
27. Effect of the oral contraceptive pill on patients undergoing controlled ovarian hyperstimulation.
Frederick J; DaCosta V; Wynter S; Reid M; Frederick C; McKenzie C
West Indian Med J; 2004 Jan; 53(1):39-43. PubMed ID: 15114893
[TBL] [Abstract][Full Text] [Related]
28. Ovarian response to controlled ovarian hyperstimulation in women with cancer is as expected according to an age-specific nomogram.
Devesa M; Martínez F; Coroleu B; Rodríguez I; González C; Barri PN
J Assist Reprod Genet; 2014 May; 31(5):583-8. PubMed ID: 24493387
[TBL] [Abstract][Full Text] [Related]
29. Two cases of polycystic ovary syndrome with onset of severe ovarian hyperstimulation syndrome following controlled ovarian stimulation with aromatase inhibitors for fertility preservation before breast cancer treatment.
Oishi S; Mekaru K; Nakamura R; Miyagi M; Akamine K; Heshiki C; Aoki Y
Taiwan J Obstet Gynecol; 2021 Sep; 60(5):931-934. PubMed ID: 34507678
[TBL] [Abstract][Full Text] [Related]
30. Ovarian Stimulation Is Safe and Effective for Patients with Gynecologic Cancer.
Akel RA; Guo XM; Moravek MB; Confino R; Smith KN; Lawson AK; Klock SC; Tanner Iii EJ; Pavone ME
J Adolesc Young Adult Oncol; 2020 Jun; 9(3):367-374. PubMed ID: 31923372
[No Abstract] [Full Text] [Related]
31. Controlled ovarian hyperstimulation for fertility preservation in women with breast cancer: Practical issues.
Park SY; Jeong K; Cho EH; Chung HW
Clin Exp Reprod Med; 2021 Mar; 48(1):1-10. PubMed ID: 33131234
[TBL] [Abstract][Full Text] [Related]
32. The ART of Thromboprophylaxis in the Prevention of Gestational Venous Thromboembolism.
Grandone E; Barcellona D; Intrieri M; Tiscia G; Nappi L; Othman M
Semin Thromb Hemost; 2023 Jun; 49(4):330-336. PubMed ID: 36368688
[TBL] [Abstract][Full Text] [Related]
33. The prevention of ovarian hyperstimulation syndrome.
Corbett S; Shmorgun D; Claman P; ;
J Obstet Gynaecol Can; 2014 Nov; 36(11):1024-1033. PubMed ID: 25574681
[TBL] [Abstract][Full Text] [Related]
34. Thrombosis following ovarian hyperstimulation syndrome.
Kasum M; Danolić D; Orešković S; Ježek D; Beketić-Orešković L; Pekez M
Gynecol Endocrinol; 2014 Nov; 30(11):764-8. PubMed ID: 25014487
[TBL] [Abstract][Full Text] [Related]
35. Elective frozen-thawed embryo transfer (FET) in women at risk for ovarian hyperstimulation syndrome.
Zech J; Brandao A; Zech M; Lugger K; Neururer S; Ulmer H; Ruttmann-Ulmer E
Reprod Biol; 2018 Mar; 18(1):46-52. PubMed ID: 29279182
[TBL] [Abstract][Full Text] [Related]
36. Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation.
O'Brien TJ; Kalmin MM; Harralson AF; Clark AM; Gindoff I; Simmens SJ; Frankfurter D; Gindoff P
Reprod Biol Endocrinol; 2013 Jul; 11():71. PubMed ID: 23883350
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular health of 9-year-old IVF offspring: no association with ovarian hyperstimulation and the in vitro procedure.
Kuiper D; Hoek A; la Bastide-van Gemert S; Seggers J; Mulder DJ; Haadsma M; Heineman MJ; Hadders-Algra M
Hum Reprod; 2017 Dec; 32(12):2540-2548. PubMed ID: 29087467
[TBL] [Abstract][Full Text] [Related]
38. Ovarian response to controlled ovarian stimulation for fertility preservation before oncology treatment: A retrospective cohort of 157 patients.
Tsampras N; Roberts SA; Gould D; Fitzgerald CT
Eur J Cancer Care (Engl); 2018 Mar; 27(2):e12797. PubMed ID: 29168588
[TBL] [Abstract][Full Text] [Related]
39. Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience.
Reddy J; Turan V; Bedoschi G; Moy F; Oktay K
J Assist Reprod Genet; 2014 Jul; 31(7):927-32. PubMed ID: 24854484
[TBL] [Abstract][Full Text] [Related]
40. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
